Elanco Animal Health Incorporated (ELAN)

Business: Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.

IPO Date: 20-Sep-2018

Pres, CEO & Director: Mr. Jeffrey N. Simmons

Exec. VP of Corp. Governance and Strategy & CFO: Mr. Todd S. Young

Listing: NYSE: ELAN

Country: United States

Headquarters: Greenfield, IN

Website: https://www.elanco.com

Market cap: $9,481.92 Mln

Revenue (TTM): $4,748.00 Mln

Earnings (TTM): $-363.00 Mln

Cash: $342.00 Mln

Total Debt: $6,134.00 Mln

Insider's Holding: 4.13%

Liquidity: Low

52 Week range: $19.34 - 37.49

Shares outstanding: 474,096,000

7 Years Aggregate:

• CFO: $1,489.70 Mln
• EBITDA: $1,428.60 Mln
• Net Profit: $-1,447.10 Mln